-
1Report
المؤلفون: Damsted, S., Finoguenov, A., Lietzen, H., Mamon, G. A., Comparat, J., Tempel, E., Dmitrieva, I., Clerc, N., Collins, C., Gozaliasl, G., Eckert, D.
المصدر: A&A 690, A52 (2024)
مصطلحات موضوعية: Astrophysics - Astrophysics of Galaxies
URL الوصول: http://arxiv.org/abs/2403.17055
-
2Academic Journal
المؤلفون: Dmitrieva, I. G.1 (AUTHOR) irina.bona.mente@gmail.com, Vasilin, V. K.2 (AUTHOR), Dotsenko, V. V.3,4 (AUTHOR) victor_dotsenko_@mail.ru, Aksenov, N. A.4 (AUTHOR)
المصدر: Russian Journal of General Chemistry. Oct2024, Vol. 94 Issue 10, p2603-2615. 13p.
مصطلحات موضوعية: *WINTER wheat, *AMINO group, *INDUCTIVE effect, *GROWTH regulators, *ACYLATION, *PYRAZOLYL compounds
-
3Academic Journal
المؤلفون: Dmitrieva, I, Nazarenko, T, Polushkina, E, Khokhlova, S, Shpirko, V, Tumyan, G, Martirosyan, Y, Sukhih, G
المصدر: Human Reproduction ; volume 37, issue Supplement_1 ; ISSN 0268-1161 1460-2350
-
4Academic Journal
المؤلفون: Dmitrieva, I A, Mileshko, L P, Prokof’eva, E V, Ivanova, N A, Rakitina, M S, Rudina, S E
المصدر: IOP Conference Series: Earth and Environmental Science ; volume 981, issue 4, page 042015 ; ISSN 1755-1307 1755-1315
-
5
-
6
-
7Academic Journal
-
8Academic Journal
-
9
-
10Academic Journal
-
11
-
12
-
13
-
14
-
15
-
16Conference
المؤلفون: Dmitrieva, I., Blanc, W., Petit, L.
المساهمون: Tampere University, Physics
مصطلحات موضوعية: 114 Physical sciences
وصف الملف: fulltext
Relation: 2020 22nd International Conference on Transparent Optical Networks, ICTON 2020; 2020-July; https://trepo.tuni.fi/handle/10024/130027
-
17Academic Journal
المؤلفون: Dmitrieva, I A, Mileshko, L P, Begun, O V, Berezhnaya, A V
المصدر: IOP Conference Series: Materials Science and Engineering ; volume 1155, issue 1, page 012072 ; ISSN 1757-8981 1757-899X
-
18Academic Journal
المؤلفون: V. Poletika S., Yu. Kolobovnikova V., O. Urazova I., O. Vasileva A., A. Dmitrieva I., K. Yankovich I., V. Novitsky V., L. Ryabova M., M. Grishchenko Yu., В. Полетика С., Ю. Колобовникова В., О. Уразова И., О. Васильева А., А. Дмитриева И., К. Янкович И., В. Новицкий В., Л. Рябова М., М. Грищенко Ю.
المساهمون: Исследование выполнено при финансовой поддержке Совета по грантам Президента Российской Федерации для государственной поддержки молодых российских ученых (МД- 2788.2019.7).
المصدر: Bulletin of Siberian Medicine; Том 19, № 3 (2020); 76-82 ; Бюллетень сибирской медицины; Том 19, № 3 (2020); 76-82 ; 1819-3684 ; 1682-0363 ; 10.20538/1682-0363-2020-19-3
مصطلحات موضوعية: galectins, T-lymphocytes, Th17, Treg, cytokines, immunosuppression, colon cancer, галектины, Т-лимфоциты, цитокины, иммуносупрессия, рак толстого кишечника
وصف الملف: application/pdf
Relation: https://bulletin.tomsk.ru/jour/article/view/2984/1793; https://bulletin.tomsk.ru/jour/article/view/2984/2230; Vesely M.D., Kershaw M.H., Schreiber R.D., Smyth M.J. Natural innate and adaptive immunity to cancer. Ann. Rev. Immunol. 2011; 29: 235–271. DOI:10.1146/annurev-immunol- 031210-101324.; Tosolini M., Kirilovsky A., Mlecnik B., Fredriksen T., Mauger S., Bindea G., Berger A., Bruneval P., Fridman W.H., Pagès F., Galon J. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, TH2, Treg, TH17) in patients with colorectal cancer. Cancer Res. 2011; 71 (4): 1263–1271. DOI:10.1158/0008-5472.CAN-10-2907.; Noguchi A., Kaneko T., Naitoh K., Masashi S., Iwai K., Maekawa R., Kamigaki T., Goto S. Impaired and imbalanced cellular immunological status assessed in advanced cancer patients and restoration of the T cell immune status by adoptive T-cell immunotherapy. International Immunopharmacology. 2014; 18 (1): 90–97. DOI:10.1016/j.intimp.2013.11.009.; Smyth M.J., Dunn G.P., Schreiber R.D. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Adv. Immunol. 2006; 90: 1–50. DOI:10.1016/S0065-2776(06)90001-7.; Chang W., Tsai M., Kuo P., Hung J. Role of galectins in lung cancer. Oncol. Lett. 2017; 14 (5): 5077–5084. DOI:10.3892/ol.2017.6882.; Orozco C.A., Martinez-Bosch N., Guerrero P.E., Vinaixa J., Dalotto-Moreno T., Iglesias M., Moreno M., Djurec M., Poirier F., Gabius H.J., Fernandez-Zapico M.E., Hwang R.F., Guerra C., Rabinovich G.A., Navarro P. Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk. Proc. Nat. Acad. Sci. USA. 2018: 115 (16): 3769–3778. DOI:10.1073/pnas.1722434115.; Chou F., Chen H., Kuo C., Sytwu H. Role of galectins in tumors and in clinical immunotherapy. Int. J. Mol. Sci. 2018; 19 (2): 430. DOI:10.3390/ijms19020430.; Колобовникова Ю.В., Дмитриева А.И., Янкович К.И., Васильева О.А., Пурлик И.Л., Новицкий В.В., Уразова О.И., Хардикова С.А. Галектин-1-опосредованная экспрессия белков-регуляторов клеточного цикла и ростовых факторов при раке желудка. Бюллетень сибирской медицины. 2017; 16 (4): 165–172. DOI:10.20538/1682-0363-2017-4-165-172.; Cedeno-Laurent F., Opperman M., Barthel S.R., Kuchroo V.K., Dimitroff C.J. Galectin-1 triggers an immunoregulatory signature in Th cells functionally defined by IL-10 expression. J. Immunol. 2012; 188 (7): 3127–3137. DOI:10.4049/jimmunol.1103433.; Cedeno-Laurent F., Watanabe R., Teague J.E., Kupper T.S., Clark R.A., Dimitroff C.J. Galectin-1 inhibits the viability; proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma. Blood. 2012; 119 (15): 3534–3538. DOI:10.1182/blood-2011-12-396457.; Fermin L.A., Chen H.Y., Wan L., Wu S.Y., Yu J.S., Huang A.C., Miaw S.C., Hsu D.K., Wu-Hsieh B.A., Liu F.T. Galectin-3 modulates Th17 responses by regulating dendritic cell cytokines. Am. J. Pathol. 2013; 183 (4): 1209–1222. DOI:10.1016/j.ajpath.2013.06.017.; Radosavljevic G., Jovanovic I., Majstorovic I., Mitrovic M., Lisnic V.J., Arsenijevic N., Jonjic S., Lukic M.L. Deletion of galectin-3 in the host attenuates metastasis of murine melanoma by modulating tumor adhesion and NK cell activity. Clin. Exp. Metastasis. 2011; 28 (5): 451–462. DOI:10.1007/s10585-011-9383-y.; Kovács-Sólyom F., Blaskó A., Fajka-Boja R., Katona R.L., Végh L., Novák J., Szebeni G.J., Krenács L., Uher F., Tubak V., Kiss R., Monostori E. Mechanism of tumor cell-induced T-cell apoptosis mediated by galectin-1. Immunol. Lett. 2010; 127 (2): 108–118. DOI:10.1016/j.imlet.2009.10.003.; Rabinovich G.A., Conejo-García J.R. Shaping the immune landscape in cancer by galectin-driven regulatory pathways. J. Mol. Biol. 2016; 428 (16): 3266–3281. DOI:10.1016/j.jmb.2016.03.021.; Van den Brûle F., Califice S., Castronovo V. Expression of galectins in cancer: a critical review. Glycoconj. J. 2002; 19 (7-9): 537–542. DOI:10.1023/B:GLYC.0000014083.48508.6a.; Thijssen V.L., Heusschen R., Caers J., Griffioen A.W. Galectin expression in cancer diagnosis and prognosis: A systematic review. Biochim. Biophys. Acta. 2015; 1855 (2): 235–247. DOI:10.1016/j.bbcan.2015.03.003.; Колобовникова Ю.В., Дмитриева А.И., Янкович К.И., Васильева О.А., Пурлик И.Л., Полетика В.С., Новицкий В.В., Уразова О.И. Экспрессия галектинов-1, 3 при раке желудка и толстой кишки с тканевой эозинофилией. Бюллетень экспериментальной биологии и медицины. 2018; 165 (2): 220–223.; Wu K.L., Chen H.H., Pen C.T., Yeh W.L., Huang E.Y., Hsiao C.C., Yang K.D. Circulating galectin-1 and 90k/mac-2bp correlated with the tumor stages of patients with colorectal cancer. Biomed. Res. Int. 2015; 2015: 306964. DOI:10.1155/2015/306964.; Hittelet A., Legendre H., Nagy N., Bronckart Y., Pector J.C., Salmon I., Yeaton P., Gabius H.J., Kiss R., Camby I. Upregulation of galectins-1 and -3 in human colon cancer and their role in regulating cell migration. Int. J. Cancer. 2003; 103 (3): 370–379. DOI:10.1002/ijc.10843.; Endo K., Kohnoe S., Tsujita E., Watanabe A., Nakashima H., Baba H., Maehara Y. Galectin-3 expression is a potent prognostic marker in colorectal cancer. Anticancer Res. 2005; 25 (4): 3117–3121.; Okada K., Shimura T., Suehiro T., Mochiki E., Kuwano H. Reduced galectin-3 expression is an indicator of unfavorable prognosis in gastric cancer. Anticancer Res. 2006; 26 (2B): 1369–1376.; Tsuboi K., Shimura T., Masuda N., Ide M., Tsutsumi S., Yamaguchi S., Asao T., Kuwano H. Galectin-3 expression in colorectal cancer: relation to invasion and metastasis. Anticancer Res. 2007; 27 (4B): 2289–2296.; Kennedy R., Celis E. Multiple roles for CD4+ T cells in anti‐tumor immune responses. Immunological Reviews. 2008; 222 (1): 129–144. DOI:10.1111/j.1600-065X.2008.00616.x.; Ling A., Lundberg I.V., Eklöf V., Wikberg M.L., Öberg Å., Edin S, Palmqvist R. The infiltration, and prognostic importance, of Th1 lymphocytes vary in molecular subgroups of colorectal cancer. J. Pathol. Clin. Res. 2016; 2 (1): 21–31.; De Simone V., Pallone F., Monteleone G., Stolfi C. Role of TH17 cytokines in the control of colorectal cancer. Oncoimmunology. 2013; 2 (12): e26617. DOI:10.4161/onci.26617.; Amicarella F., Muraro M.G., Hirt C., Cremonesi E., Padovan E., Mele V., Governa V., Han J., Huber X., Droeser R.A., Zuber M., Adamina M., Bolli M., Rosso R., Lugli A., Zlobec I., Terracciano L., Tornillo L., Zajac P., Eppenberger-Castori S., Trapani F., Oertli D., Iezzi G. Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer. Gut. 2017; 66 (4): 692–704. DOI:10.1136/gutjnl-2015-310016.; Bonertz A., Weitz J., Pietsch D.H., Rahbari N.N., Schlude C., Ge Y., Juenger S., Vlodavsky I., Khazaie K., Jaeger D., Reissfelder C., Antolovic D., Aigner M., Koch M., Beckhove P. Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma. J. Clin. Invest. 2009; 119 (11): 3311–3321. DOI:10.1172/JCI39608.; Васильева О.А., Прохоренко Т.С., Зима А.П., Новицкий В.В. Влияние галектинов на дифференцировку и функциональную активность Th-лимфоцитов in vitro. Медицинская иммунология. 2015; 17 (5): 14.; Toscano M.A., Bianco G.A., Ilarregui J.M., Croci D.O., Correale J., Hernandez J.D., Zwirner N.W., Poirier F., Riley E.M., Baum L.G., Rabinovich G.A. Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat. Immunol. 2007; 8 (8): 825–834. DOI:10.1038/ni1482.; Васильева О.А., Якушина В.Д., Рязанцева Н.В., Новицкий В.В., Таширева Л.А., Старикова Е.Г., Зима А.П., Прохоренко Т.С., Краснова Ю.В., Небесная И.С. Регуляция экспрессии генов транскрипционных факторов дифференцировки T-лимфоцитов CD4+ галектином-3 in vitro. Молекулярная биология. 2013; 47 (6): 1004–1010. DOI:10.7868/S0026898413060165.; MacKinnon A.C., Gibbons M.A., Farnworth S.L., Leffler H., Nilsson U.J., Delaine T., Simpson A.J., Forbes S.J., Hirani N., Gauldie J., Sethi T. Regulation of Transforming Growth Factor-β1–driven Lung Fibrosis by Galectin-3. Am. J. Respir. Crit. Care Med. 2012; 185 (5): 537–546. DOI:10.1164/rccm.201106-0965OC.; https://bulletin.tomsk.ru/jour/article/view/2984
-
19Academic Journal
المؤلفون: Grigorev, G V, Dmitrieva, I N, Kotenev, E V
المصدر: IOP Conference Series: Materials Science and Engineering ; volume 817, issue 1, page 012011 ; ISSN 1757-8981 1757-899X
-
20Academic Journal
المؤلفون: Zargaryan, E V, Zargaryan, Y A, Kapc, I V, Sakharova, O N, Kalyakina, I M, Dmitrieva, I A
المصدر: IOP Conference Series: Materials Science and Engineering ; volume 919, issue 2, page 022027 ; ISSN 1757-8981 1757-899X